A growing number of legal claims suggest that silicone breast implants may cause a wide range of serious side effects, including excessive levels of heavy metals in the blood stream and silicone toxicity. While the number of pending claims is small, plaintiffs charge that thousands of women may be at risk for breast implant-related illness and complications.
The attorneys at Bernstein Liebhard LLP are now evaluating potential lawsuits on behalf of women who developed debilitating symptoms or serious health conditions following breast augmentation or reconstruction with silicone implants, including:
To learn if you could be entitled to compensation for breast implant side effects, please contact our office today by calling (888) 994-5118.
In 1992, the U.S. Food & Drug Administration (FDA) all but banned the use of silicone breast implants due to concerns over their potential side effects. By the time the agency acted, thousands of women had already filed suit for autoimmune and connective tissue disorders allegedly associated with the devices. The FDA rescinded its ban in 2006, despite lingering safety concerns. However, only three companies — Mentor Worldwide, Allergan Plc, and Sientra Inc.– have been authorized by the agency to market silicone implants in the U.S.
The majority of lawsuits filed over silicone breast implants in the 1980s and 1990s have been resolved. However, several recent filings suggest that a new wave of litigation could be about to get underway:
In March 2017, the FDA confirmed a small, but significant risk of anaplastic large cell lymphoma (ALCL) among breast implant patients. The agency had been investigating the potential for breast implant cancer since 2011, and had since received more than 350 reports of the rare malignancy in patients with silicon or saline devices. At least 9 women had died as result of the disease.
ALCL is a form of non-Hodgkin’s lymphoma that affects the cells of the immune system. When it occurs in patients with implants, it is usually seen in scar tissue around the device. However, ALCL can also occur in the skin or lymph nodes. The FDA noted that ALCL was more likely to occur in patients with textured implants, rather than those with smooth devices.
ALCL is treatable if detected early. The FDA is advising women to monitor their breast implants and contact their doctors promptly if they notice pain, swelling or any changes in or around the device.
Bernstein Liebhard LLP is offering free legal reviews to women who may be suffering from breast implant side effects. If or a loved one developed complications or illnesses that could be related to silicone breast implants, please call (888) 994-5118 to learn more about the legal options available to you.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.